Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Eye (London, England)|October 9, 2010
Central serous chorioretinopathy: an update on pathogenesis and treatmentM Gemenetzi, G De Salvo, A J LoteryJournal of Medical Genetics|September 11, 1998
Fine localisation of the gene for central areolar choroidal dystrophy on chromosome 17pA E Hughes, A J Lotery, G SilvestriEye (London, England)|June 20, 2015
Dementia of the eye: the role of amyloid beta in retinal degenerationJ A Ratnayaka, L C Serpell, A J LoteryInternational Journal of Immunogenetics|November 30, 2005
HLA and eye disease: a synopsisS V Goverdhan, A J Lotery, W M HowellEye (London, England)|April 30, 2011
X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotypeS Khandhadia, D Trump, G Menon, et al.International Ophthalmology|January 1, 1995
Treatment and long-term follow up of a capillary angioma of the optic discP B Johnston, A J Lotery, W C LoganEye (London, England)|February 11, 2017
One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degenerationH Almuhtaseb, S Kanavati, S R Rufai, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 28, 2011
A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibilityA Taylor, K Lachlan, R M Manners, et al.Eye (London, England)|January 1, 1997
Familial deafness associated with iris degeneration and glaucomaP Rundle, A J Lotery, D B Archer, et al.Eye (London, England)|June 17, 2017
Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users GroupH Almuhtaseb, R L Johnston, J S Talks, et al.Pageof 5